Asthma Friendly Pharmacies: A Model to Improve Communication and Collaboration among Pharmacists, Patients, and Healthcare Providers

Berry, Tricia; Prosser, Theresa R.; Wilson, Kristin D.; Castro, Mario

doi:10.1007/s11524-010-9514-9

Cited by 29 publications

(44 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…For these reasons, on practical ground the community pharmacies interventional role can be focused on less time consuming outcomes, such as the assessment of asthma control or the inhaler technique verification. Furthermore, an active role in asthma management can be feasible for a limited number of pharmacies, maybe through the creation of dedicated networks (37).…”

Section: Discussionmentioning

confidence: 99%

Evaluation of asthma control in the pharmacy: an Italian cross-sectional study

Caminati

Senna

Segala³

et al. 2017

Eur Ann Allergy Clin Immunol

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Evaluation of asthma control in the pharmacy: an Italian cross-sectional study

Caminati

Senna

Segala³

et al. 2017

Eur Ann Allergy Clin Immunol

View full text Add to dashboard Cite

show abstract

“…Asthma-Friendly Pharmacy' is the model of integration pharmaceutical care with the care provided by another healthcare team member. Last but not least, pharmaceutical services in this program are beneficial for promoting interprofessional collaboration in healthcare system [31].…”

Section: Health Education In the Community Pharmacymentioning

confidence: 99%

The Pharmaceutical Care in Asthma—Polish and Global Perspective

Świeczkowski

Poniatowski²,

Merks

et al. 2016

Advances in Respiratory Medicine

View full text Add to dashboard Cite

The pharmaceutical care is a pharmacist's contribution to the care of individual patients and leads to optimize the use of drugs. The pharmaceutical care may improve adherence, clinical effectiveness of providing therapy and improve the health-related quality of life. The conducted literature review confirmed that pharmaceutical care and advanced pharmaceutical services are clinical effective in asthma. The implementation of pharmaceutical care under Polish conditions is currently insufficient and remains challenging for the future. Herein we should admit, that the polish government has recently put an effort to appoint specially dedicated team establishing a program of reimbursed pharmaceutical care. This move should be considered as a new phase for amendments community pharmacy in Poland. The experience of different health care systems, including for instance United Kingdom, Australia or Canada, might be used in the process of changing Polish perspective. Herein, we have reviewed the literature and highlighted the services creating the program of pharmaceutical care in asthma. This unique work describes the complex nature of optimal pharmaceutical services emphasizing the strong necessity of multidimensional approach in this field.

show abstract

“…27 Community pharmacy interventions also have demonstrated an impact in numerous studies. 28,29 Beyond the clinical practice setting, patient and parental factors also are amenable to intervention. In a randomized trial of 305 parent-child dyads, Web-based education plus nurse case management significantly improved asthma control compared with usual care.…”

Section: Asthma Emergency Visits After Ics-rxmentioning

confidence: 99%

Timing of Emergency Department Visits for Childhood Asthma after Initial Inhaled Corticosteroid Use

Rust

Zhang²,

Holloway³

et al. 2015

Population Health Management

View full text Add to dashboard Cite

Inhaled corticosteroids can prevent acute exacerbations and emergency visits when used as part of a chronic care plan for long-term control of asthma, but low patient adherence and inadequate provider prescribing (clinical inertia) can limit these benefits. State Medicaid programs are a major source of insurance coverage for low-income children, paying for medications and preventive care, as well as bearing the cost of adverse outcomes for common chronic conditions in childhood, such as asthma. This study measured the incidence and timing of emergency department (ED) visits in the first 90 days after an initial inhaled corticosteroid prescription (ICS-Rx) among 43,156 Medicaid-enrolled children with a diagnosis of asthma in 14 southern states in 2007. One in 5 children (19.6%) with asthma had at least 1 ED visit in the first 90 days after initial ICS-Rx; 10% of these visits occurred within the first 48 hours, and 25% occurred within the first week. Continued ICS-Rx use was associated with lower risk of an ED visit. There were no racial differences in the ED visit rates. Initial ICSRx for Medicaid-enrolled children is a warning flag for short-term risk of asthma-related ED visits, whereas continued ICS-Rx use is protective for at least 90 days. Primary care follow-up may be needed within the first 2 days after initial ICS-Rx to prevent adverse outcomes. Medicaid programs could use claims data for surveillance of adherence to guideline-concordant therapy and for sentinel events marking windows of a higher risk for ED visits.

show abstract

Asthma Friendly Pharmacies: A Model to Improve Communication and Collaboration among Pharmacists, Patients, and Healthcare Providers

Cited by 29 publications

References 9 publications

Evaluation of asthma control in the pharmacy: an Italian cross-sectional study

Evaluation of asthma control in the pharmacy: an Italian cross-sectional study

The Pharmaceutical Care in Asthma—Polish and Global Perspective

Timing of Emergency Department Visits for Childhood Asthma after Initial Inhaled Corticosteroid Use

Contact Info

Product

Resources

About